2 gastrointestinal drugs get FDA approval

Two drugs treating gastrointestinal illnesses have received FDA approval, Phathom Pharmaceuticals said May 3. 

Advertisement
By: Patsy Newitt

Voquezna Triple Pak and Voquezna Dual Pak both treat helicobacter pylori and are supplied in blister packs. 

A commercial launch is expected in the third quarter of 2022. 

 

Beyond SEO: How AI & online reputation influence which doctors get chosen

Recommended OnDemand Webinar

Advertisement

Next Up in GI & Endoscopy

  • 5 GI leaders to watch in 2026

    Below is a list of five gastroenterology leaders in the U.S. who have made a positive impact on their organizations…

    By: Sophie Eydis

  • GI case mix is shifting — here's how

    Chicago-based GI Partners of Illinois saw its GI case mix tilt toward more complex, chronic and multidisciplinary care in 2025,…

    By: Patsy Newitt
Advertisement

Comments are closed.